News | January 22, 2025
Sunshine Biopharma launches Olanzapine and Olanzapine ODT
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
Phase 3 data expected in the second half of 2024
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
Subscribe To Our Newsletter & Stay Updated
